107 related articles for article (PubMed ID: 18819401)
1. [Interaction of S- and R-lipopolysaccharides of Francisella tularensis with lypopolysaccharide-binding protein of human serum].
Onoprienko NN; Pavlovich NV
Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):16-21. PubMed ID: 18819401
[TBL] [Abstract][Full Text] [Related]
2. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
[TBL] [Abstract][Full Text] [Related]
3. Basis for the failure of Francisella tularensis lipopolysaccharide to prime human polymorphonuclear leukocytes.
Barker JH; Weiss J; Apicella MA; Nauseef WM
Infect Immun; 2006 Jun; 74(6):3277-84. PubMed ID: 16714555
[TBL] [Abstract][Full Text] [Related]
4. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
Fulop M; Mastroeni P; Green M; Titball RW
Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
[TBL] [Abstract][Full Text] [Related]
5. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
Kieffer TL; Cowley S; Nano FE; Elkins KL
Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
[TBL] [Abstract][Full Text] [Related]
6. [The capacity of avirulent forms of Francisella tularensis for dissemination and proliferation in the host body].
Tsimbalistova MV; Pavlovich NV; Sorokin VM; Tynkevich NK
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):10-3. PubMed ID: 8701638
[TBL] [Abstract][Full Text] [Related]
7. [Phase variations of Francisella tularensis lipopolysaccharide in human infection and immunization].
Aronova NV; Pavlovich NV
Zh Mikrobiol Epidemiol Immunobiol; 2005; (4):8-12. PubMed ID: 16146218
[TBL] [Abstract][Full Text] [Related]
8. Francisella tularensis resistance to bactericidal action of normal human serum.
Sorokin VM; Pavlovich NV; Prozorova LA
FEMS Immunol Med Microbiol; 1996 Mar; 13(3):249-52. PubMed ID: 8861038
[TBL] [Abstract][Full Text] [Related]
9. [The use if Francisella tularensis lipopolysaccharide in the dot solid phase enzyme immunoassay].
Aronova NV; Pavlovich NV
Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):75-8. PubMed ID: 11220974
[TBL] [Abstract][Full Text] [Related]
10. Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence.
Fulop M; Manchee R; Titball R
FEMS Immunol Med Microbiol; 1996 Mar; 13(3):245-7. PubMed ID: 8861037
[TBL] [Abstract][Full Text] [Related]
11. [The resistance of Francisella tularensis to the bactericidal action of normal serum as a criterion for evaluating the virulence of the bacterium].
Pavlovich NV; Sorokin VM; Blagorodova NS
Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):7-10. PubMed ID: 8820667
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of the immune response of a rabbit to antigens to live and killed Francisella species bacteria].
Aronova NV; Pavlovich NV
Mol Gen Mikrobiol Virusol; 2001; (2):26-30. PubMed ID: 11449797
[TBL] [Abstract][Full Text] [Related]
14. [ROLE OF VARIOUS ANTIGENIC PREPARATIONS OF FRANCISELLA TULARENSIS IN FORMATION OF ALLERGY REACTION IN HUMANS AND ANIMALS].
Onoprienko NN; Aronova NV; Pavlovich NV
Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):22-9. PubMed ID: 27029112
[TBL] [Abstract][Full Text] [Related]
15. [The determination of the antigenic determinant of protective monoclonal antibodies specific to the Francisella tularensis lipopolysaccharide].
Khlebnikov VS; Golovlev IR; Tokhtamysheva NV; Averin SF; Kulevatskiĭ DP; Grechko GK; Averina AA; Vetchinin SS
Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):83-8. PubMed ID: 7520655
[TBL] [Abstract][Full Text] [Related]
16. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
[TBL] [Abstract][Full Text] [Related]
17. Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist.
Walters KA; Olsufka R; Kuestner RE; Wu X; Wang K; Skerrett SJ; Ozinsky A
BMC Genomics; 2015 Oct; 16():874. PubMed ID: 26510639
[TBL] [Abstract][Full Text] [Related]
18. Virulence determinants and protective antigens of Francisella tularensis.
Sjöstedt A
Curr Opin Microbiol; 2003 Feb; 6(1):66-71. PubMed ID: 12615222
[TBL] [Abstract][Full Text] [Related]
19. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide.
Figueiredo MD; Salter CE; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):275-80. PubMed ID: 18023485
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
